Dr. Pradeep Kumar Karumanchi

Dr. Pradeep Kumar Karumanchi is a Consultant Radiation Oncologist at Yashoda Hospitals, Somajiguda, in Hyderabad, bringing over 16 years of clinical expertise in advanced cancer care. He holds a DNB in Radiation Oncology from Healthcare Global Cancer Hospital and has completed specialized training in Precision Oncology at the Université de Genève, Switzerland, Thoracic Oncology at the University of Michigan, and CyberKnife CNS training with Accuray in the USA. His clinical practice is anchored in high-precision radiotherapy techniques, making him one of India's pioneers in MR LINAC technology for real-time adaptive, MRI-guided radiation therapy.

Dr. Karumanchi specializes in delivering complex cancer treatments using cutting-edge modalities including CyberKnife Radiosurgery, Stereotactic Body Radiation Therapy (SBRT), Image-Guided Radiation Therapy (IMRT), Brachytherapy, and 4D Gated Radiation Therapy. He is recognized for his expertise in hypofractionated radiotherapy—offering shorter, more efficient treatment cycles—and innovative Functional Radiosurgery for both malignant and benign conditions such as trigeminal neuralgia, Parkinson's disease, and keloids. His clinical focus spans head and neck cancers, brain tumors, breast cancer, lung cancer, prostate cancer, gastrointestinal cancers, and gynecological malignancies.

International patients—particularly from the Gulf region, Africa, and SAARC countries—benefit from Dr. Karumanchi's multilingual approach (fluent in English, Hindi, and Telugu) and his track record of managing complex, referred oncology cases. He actively engages in clinical research and is a strong advocate of Radiomics and Artificial Intelligence in Oncology, publishing regularly in national and international forums. Patients report a patient-centric approach combined with transparent, evidence-based treatment planning.

Yashoda Hospitals, Somajiguda, is a state-of-the-art tertiary care center equipped with the latest radiotherapy infrastructure, including MR LINAC and CyberKnife systems, backed by a multidisciplinary oncology team. The hospital's robust international patient services, NABH accreditation, and commitment to minimally invasive, precision-based care make it an ideal destination for international cancer patients seeking world-standard treatment in India. Dr. Karumanchi's combination of international training, pioneering technology adoption, and clinical acumen makes him a preferred choice for patients seeking advanced radiotherapy in a trusted, well-resourced setting.